{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T02:14:38Z","timestamp":1758593678314,"version":"3.44.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hand, foot, and mouth disease (HFMD) is a viral infection, primarily caused by gastrointestinal viruses. Xuebijing (XBJ) injection, widely used in China for treating inflammatory conditions like sepsis, may offer therapeutic benefits for HFMD. This study aimed to evaluate the efficacy and safety of adjunctive XBJ therapy for HFMD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>Databases were systematically searched until February 2024. Meta-analysis used random or fixed-effect models, with outcomes reported as standardized mean differences (SMD) or relative risks (RR) and 95% confidence intervals (CI). Heterogeneity was assessed via Cochran\u2019s <jats:italic toggle=\"yes\">Q<\/jats:italic> test and <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> index. Network pharmacology, molecular docking, and molecular dynamics simulations identified active XBJ components and their targets in HFMD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six randomized controlled trials (RCTs) involving 786 participants were included. XBJ significantly improved the total effective rate (RR\u00a0=\u00a01.19, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01), shortened fever duration (SMD\u00a0=\u00a0\u2212\u00a01.78, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01), reduced rash resolution time (SMD\u00a0=\u00a0\u2212\u00a01.13, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01), and decreased hospital stay (SMD\u00a0=\u00a0\u2212\u00a01.20, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). Pharmacological analysis identified four active XBJ components targeting IFN-\u03b3, TLR4, and TNF-\u03b1 in HFMD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>XBJ as adjunctive therapy improves outcomes in HFMD and is safe, with specific molecular targets identified for its therapeutic effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003379","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:57:06Z","timestamp":1747731426000},"page":"4414-4425","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical efficacy and mechanistic insights of Xuebijing in hand, foot, and mouth disease: a meta-analysis with integrated pharmacological approaches"],"prefix":"10.1097","volume":"87","author":[{"given":"Jiaqi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Trauma Center, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boying","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyuan","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Qilu Medical University, Zibo, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8382-0973","authenticated-orcid":false,"given":"Hao","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Trauma Center, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"101596","DOI":"10.1016\/j.eclinm.2022.101596","article-title":"Immunogenicity and safety of an Enterovirus 71 vaccine in children aged 36-71 months: a double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial","volume":"52","author":"Tong","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"752978","DOI":"10.3389\/fphar.2022.752978","article-title":"Clinical evidence on the use of Chinese herbal medicine for acute infectious diseases: an overview of systematic reviews","volume":"13","author":"Luo","year":"2022","journal-title":"Front Pharmacol"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12519-018-0189-8","article-title":"Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition)","volume":"14","author":"Li","year":"2018","journal-title":"World J Pediatr"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12929-023-00908-4","article-title":"Current status of hand-foot-and-mouth disease","volume":"30","author":"Zhu","year":"2023","journal-title":"J Biomed Sci"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"e0271721","DOI":"10.1128\/mbio.02717-21","article-title":"Acyl-coenzyme a synthetase long-chain family member 4 is involved in viral replication organelle formation and facilitates virus replication via ferroptosis","volume":"13","author":"Kung","year":"2022","journal-title":"mBio"},{"key":"R6-20250922","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17460441.2019.1659241","article-title":"Recent progress and challenges in drug development to fight hand, foot and mouth disease","volume":"15","author":"Lim","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"R7-20250922","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3201\/eid2410.171953","article-title":"Emerging enteroviruses causing hand, foot and mouth disease, China, 2010-2016","volume":"24","author":"Li","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R8-20250922","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/v14102190","article-title":"Activation of host cellular signaling and mechanism of Enterovirus 71 viral proteins associated with hand, foot and mouth disease","volume":"14","author":"Swain","year":"2022","journal-title":"Viruses"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"9273241","DOI":"10.1155\/2020\/9273241","article-title":"Predicting severe Enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines","volume":"2020","author":"Zhang","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/vaccines10111829","article-title":"Laboratory indicators for identifying hand, foot, and mouth disease severity: a systematic review and meta-analysis","volume":"10","author":"Xie","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.biopha.2018.07.111","article-title":"Xuebijing injection induces anti-inflammatory-like effects and downregulates the expression of TLR4 and NF-kappaB in lung injury caused by dichlorvos poisoning","volume":"106","author":"He","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fphar.2018.00743","article-title":"Efficacy and safety of Xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front Pharmacol"},{"key":"R13-20250922","doi-asserted-by":"crossref","first-page":"952938","DOI":"10.3389\/fphar.2022.952938","article-title":"Traditional Chinese Medicine: a promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms","volume":"225","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"140764","DOI":"10.1155\/2014\/140764","article-title":"Comparison between Chinese herbal medicines and conventional therapy in the treatment of severe hand, foot, and mouth disease: a randomized controlled trial","volume":"2014","author":"Li","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"R16-20250922","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"R18-20250922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"article-title":"dmetar: Companion R Package For The Guide \u2018Doing Meta-Analysis in R\u2019","year":"2019","author":"Harrer","key":"R19-20250922"},{"key":"R20-20250922","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12874-020-01169-7","article-title":"Using trial sequential analysis for estimating the sample sizes of further trials: example using smoking cessation intervention","volume":"20","author":"Claire","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"13031","DOI":"10.1002\/cpbi.5","article-title":"The genecards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative Toxicogenomics Database (CTD): update 2023","volume":"51(D1)","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pinero","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R24-20250922","doi-asserted-by":"crossref","first-page":"258","DOI":"10.53388\/TMR201814086","article-title":"Recent advances in network pharmacology applications in Chinese herbal medicine","volume":"3","author":"Hao","year":"2018","journal-title":"Tradit Med Res"},{"key":"R25-20250922","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"The Innov"},{"key":"R26-20250922","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"key":"R27-20250922","first-page":"110","article-title":"Clinical efficacy observation on 48 cases of hand-foot-mouth disease treated with Xuebijing and ribavirin combined with Kangfuxin liquid","volume":"2","author":"Chen","year":"2015","journal-title":"E-J Transl Med"},{"key":"R28-20250922","first-page":"1289","article-title":"Clinical effects of Xuebijing in the treatment of stage 1 hand-foot-mouth disease","volume":"38","author":"Yi","year":"2016","journal-title":"Guangxi Med J"},{"key":"R29-20250922","first-page":"105","article-title":"Clinical curative effect observation of Xuebijing injection in the treatment of hand-foot-mouth disease","volume":"32","author":"Lin","year":"2016","journal-title":"Chinese Community Doctors"},{"key":"R30-20250922","first-page":"32","article-title":"Xuebijing in the treatment of children with hand-foot-mouth disease","volume":"24","author":"Zhu","year":"2018","journal-title":"J Pediatr Pharmacol"},{"key":"R31-20250922","first-page":"628","article-title":"Observations on the therapeutic effect of Xuebijing injection in the treatment of 35 cases of severe hand-foot-mouth disease","volume":"29","author":"Jiang","year":"2016","journal-title":"J Med Theory Pract"},{"key":"R32-20250922","first-page":"67","article-title":"Clinical observation on 95 cases of hand-foot-mouth disease combined with encephalitis treated with ribavirin and Xuebijing","volume":"13","author":"Shi","year":"2010","journal-title":"Chin J Pract Nerv Dis"},{"key":"R33-20250922","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12879-019-3878-6","article-title":"Clinical characteristics and managements of severe hand, foot and mouth disease caused by Enterovirus A71 and Coxsackievirus A16 in Shanghai, China","volume":"19","author":"Cai","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R34-20250922","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/1040841X.2011.580723","article-title":"The virology and developments toward control of human enterovirus 71","volume":"37","author":"Yi","year":"2011","journal-title":"Crit Rev Microbiol"},{"key":"R35-20250922","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/B978-0-444-53488-0.00018-3","article-title":"Enterovirus\/picornavirus infections","volume":"123","author":"Jubelt","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"R36-20250922","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jech-2014-203836","article-title":"Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges","volume":"68","author":"Sabanathan","year":"2014","journal-title":"J Epidemiol Community Health"},{"key":"R37-20250922","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/idoj.idoj_423_22","article-title":"Foot, and mouth disease (HFMD) in India: a review on clinical manifestations, molecular epidemiology, pathogenesis, and prevention","volume":"14","author":"Tikute","year":"2023","journal-title":"Indian Dermatol Online J"},{"key":"R38-20250922","doi-asserted-by":"crossref","first-page":"1187035","DOI":"10.3389\/fimmu.2023.1187035","article-title":"Cell membrane-bound toll-like receptor-1\/2\/4\/6 monomers and -2 heterodimer inhibit Enterovirus 71 replication by activating the antiviral innate response","volume":"14","author":"Sun","year":"2023","journal-title":"Front Immunol"},{"key":"R39-20250922","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tschope","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R40-20250922","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"R41-20250922","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","volume":"38","author":"Newton","year":"2016","journal-title":"Semin Immunopathol"},{"key":"R42-20250922","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/345905","article-title":"Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system","volume":"36","author":"Lin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R43-20250922","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.21037\/apm-20-1478","article-title":"Xuebijing injection in the treatment of COVID-19: a retrospective case-control study","volume":"9","author":"Guo","year":"2020","journal-title":"Ann Palliat Med"},{"key":"R44-20250922","doi-asserted-by":"crossref","first-page":"153543","DOI":"10.1016\/j.phymed.2021.153543","article-title":"Network pharmacology to explore the anti-inflammatory mechanism of Xuebijing in the treatment of sepsis","volume":"85","author":"Zhou","year":"2021","journal-title":"Phytomedicine"},{"key":"R45-20250922","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.3390\/ijms222011078","article-title":"Research progress in Chinese herbal medicines for treatment of sepsis: pharmacological action, phytochemistry, and pharmacokinetics","volume":"22","author":"Cheng","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R46-20250922","doi-asserted-by":"crossref","first-page":"113301","DOI":"10.1016\/j.jep.2020.113301","article-title":"The current evidence for the treatment of sepsis with Xuebijing injection: bioactive constituents, findings of clinical studies and potential mechanisms","volume":"265","author":"Li","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R47-20250922","doi-asserted-by":"crossref","first-page":"627716","DOI":"10.3389\/fphar.2021.627716","article-title":"Xuebijing protects against septic acute liver injury based on regulation of GSK-3beta pathway","volume":"12","author":"Cao","year":"2021","journal-title":"Front Pharmacol"},{"key":"R48-20250922","first-page":"352642","article-title":"Xuebijing injection promotes M2 polarization of macrophages and improves survival rate in septic mice","volume":"2015","author":"Liu","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"R49-20250922","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jep.2017.10.001","article-title":"Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis","volume":"211","author":"Chen","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"R50-20250922","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virusres.2013.11.021","article-title":"Peripheral T lymphocyte subset imbalances in children with Enterovirus 71-induced hand, foot and mouth disease","volume":"180","author":"Li","year":"2014","journal-title":"Virus Res"},{"key":"R51-20250922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13040-020-00227-6","article-title":"Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology","volume":"13","author":"Zheng","year":"2020","journal-title":"BioData Min"},{"key":"R52-20250922","first-page":"178","article-title":"Efficacy of Xuebijing injection for the treatment of coronavirus disease 2019 via network pharmacology","volume":"5","author":"Zhang","year":"2020","journal-title":"Tradit Med Res"},{"key":"R53-20250922","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13020-020-00326-w","article-title":"The potential insights of Traditional Chinese Medicine on treatment of COVID-19","volume":"15","author":"Tong","year":"2020","journal-title":"Chin Med"},{"key":"R54-20250922","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1142\/S0192415X07004709","article-title":"Antiviral effects of Salvia miltiorrhiza (Danshen) against Enterovirus 71","volume":"35","author":"Wu","year":"2007","journal-title":"Am J Chin Med"},{"key":"R55-20250922","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/10286020.2019.1645132","article-title":"Two new tanshinone derivatives from the rhizomes of Salvia miltiorrhiza and their antiviral activities","volume":"22","author":"Yin","year":"2020","journal-title":"J Asian Nat Prod Res"},{"key":"R56-20250922","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12275-013-3282-7","article-title":"Dysregulation of KSHV replication by extracts from Carthamus tinctorius L","volume":"51","author":"Lee","year":"2013","journal-title":"J Microbiol"},{"key":"R57-20250922","doi-asserted-by":"crossref","first-page":"563516","DOI":"10.3389\/fgene.2021.563516","article-title":"Proteomics landscape of host-pathogen interaction in Acinetobacter baumannii infected mouse lung","volume":"12","author":"Li","year":"2021","journal-title":"Front Genet"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T07:02:05Z","timestamp":1758524525000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003379","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"2024-10-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}